Prognostic model for second progression‐free survival and overall survival in patients with high‐risk metastatic hormone‐sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy.

Autor: Narita, Shintaro, Yanagisawa, Takafumi, Hatakeyama, Shingo, Hata, Kenichi, Fujita, Kazutoshi, Ueda, Takashi, Tanaka, Toshikazu, Maita, Shinya, Chiba, Shuji, Sato, Hiromi, Sekine, Yuya, Kobayashi, Mizuki, Kashima, Soki, Yamamoto, Ryohei, Numakura, Kazuyuki, Saito, Mitsuru, Takayama, Koichiro, Okane, Katsumi, Ishida, Toshiya, Horikawa, Yohei
Zdroj: Prostate; Jan2025, Vol. 85 Issue 1, p73-81, 9p
Databáze: Complementary Index
Externí odkaz: